EUVIMEDEUVIMED entdecken
Open Access

Therapeutic Updates on the Management of Tinea Corporis or Cruris in the Era of Trichophyton Indotineae

Ananta Khurana, Savitha Sharath, Kabir Sardana, Anuradha Chowdhary, Sanjeet Panesar

Indian Journal of Dermatology · 2023-09 · 68 (5) · 525-540

DOI: 10.4103/ijd.ijd_832_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Dermatology, 2023-09. Verfasst von Ananta Khurana und 4 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Dermatology, Venereology and Leprosy, ABVIMS and Dr. RML Hospital, New Delhi, India. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence and spread of Trichophyton indotineae ( T. indotineae ) has led to a sea change in the prescription practices of clinicians regarding the management of dermatophytic skin infections. An infection easily managed with a few weeks of antifungals, tinea corporis or cruris, is now often chronic and recurrent and requires prolonged treatment. Rising resistance to terbinafine, with documented squalene epoxidase (SQLE) gene mutations, and slow clinical response to itraconazole leave clinicians with limited treatment choices. However, in these testing times, it is essential that the tenets of antifungal stewardship be followed in making therapeutic decisions, and that the existing armamentarium of antifungals be used in rationale ways to counter this extremely common cutaneous infection, while keeping the growing drug resistance among dermatophytes in check. This review provides updated evidence on the use of various systemic antifungals for dermatophytic infection of the glabrous skin, especially with respect to the emerging T. indotineae species, which is gradually becoming a worldwide concern.

Schlagwörter

Stichwörter der Autor:innen

AntifungalsTrichophyton indotineaegriseofulvinitraconazoleketoconazolemutationsresistancesqualene epoxidaseterbinafinetinea corporistinea cruristreatmentvoriconazole

Autor:innen und Institutionen

  • From the Department of Dermatology, Venereology and Leprosy, ABVIMS and Dr. RML Hospital, New Delhi, India.
  • Medical Mycology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.
  • Department of Community Medicine, ABVIMS and Dr. RML Hospital, New Delhi, India.

Zitieren

APA

Khurana, A., Sharath, S., Sardana, K., Chowdhary, A., & Panesar, S. (2023). Therapeutic Updates on the Management of Tinea Corporis or Cruris in the Era of Trichophyton Indotineae. Indian Journal of Dermatology, 68(5), 525-540. https://doi.org/10.4103/ijd.ijd_832_23

Vancouver

Khurana A, Sharath S, Sardana K, Chowdhary A, Panesar S. Therapeutic Updates on the Management of Tinea Corporis or Cruris in the Era of Trichophyton Indotineae. Indian Journal of Dermatology. 2023;68(5):525-540. doi:10.4103/ijd.ijd_832_23

BibTeX
@article{Khurana2023,
  author = {Khurana, Ananta and Sharath, Savitha and Sardana, Kabir and Chowdhary, Anuradha and Panesar, Sanjeet},
  title = {Therapeutic Updates on the Management of Tinea Corporis or Cruris in the Era of Trichophyton Indotineae},
  journal = {Indian Journal of Dermatology},
  year = {2023},
  volume = {68},
  number = {5},
  pages = {525--540},
  doi = {10.4103/ijd.ijd_832_23}
}
Kostenlos starten →